Skip to main content

Table 3 Lung function in the two different groups of patients with acute atypical infection (AAI) and patients without AAI during the study period.

From: Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection

 

Patients with AAI (22)

Patients without AAI (36)

p

PEF predicted (L/min)

546.9 ± 85.4

509.8 ± 101.9

0.159

PEF admission (L/min)

205.9 ± 104.1

276.9 ± 117.3

0.023

PEF % of predicted on admission

38.3 ± 18.3

55.3 ± 19.5

0.002

FEV1% on admission

39.73 ± 19.64 (11 pts)

58.53 ± 20.43 (19 pts)

0.02

FEV1% Visit 1 (2–4 days)

70.91 ± 25.6

89.14 ± 17.07

0.002

FEV1% Visit 2 (10–14 days)

76.30 ± 24.54

92.91 ± 13.89

0.002

FEV1% Visit 3 (4–8 weeks)

85.05 ± 19.13

92.26 ± 14.44

0.114

Acute severe attack (number of patients)

15

12

0.01

OR 4.29, 95% CI 1.38–13.32